NAVIDEA BIOPHARMACEUTICALS, INC. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Navidea Biopharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2023.
  • Navidea Biopharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 10, 2023 was 100M shares, a 209% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 100M +67.7M +209% Nov 10, 2023 10-Q 2023-11-14
Q2 2023 99.8M +69.5M +229% Aug 9, 2023 10-Q 2023-08-11
Q1 2023 32.9M +2.55M +8.42% Mar 17, 2023 10-K 2023-03-27
Q3 2022 32.4M +2.18M +7.21% Nov 7, 2022 10-Q 2022-11-14
Q2 2022 30.4M +204K +0.68% Aug 8, 2022 10-Q 2022-08-15
Q1 2022 30.3M +1.73M +6.06% Mar 18, 2022 10-K 2022-03-28
Q3 2021 30.2M +3.5M +13.1% Nov 5, 2021 10-Q 2021-11-12
Q2 2021 30.2M +4.32M +16.7% Aug 6, 2021 10-Q 2021-08-12
Q1 2021 28.6M +8.13M +39.8% Mar 15, 2021 10-K 2021-03-26
Q3 2020 26.7M +8.61M +47.6% Nov 6, 2020 10-Q 2020-11-13
Q2 2020 25.8M +7.79M +43.1% Aug 7, 2020 10-Q 2020-08-14
Q1 2020 20.4M -180M -89.8% Mar 2, 2020 10-K 2020-03-18
Q3 2019 18.1M -164M -90.1% Nov 1, 2019 10-Q 2019-11-08
Q2 2019 18.1M -146M -89% Aug 1, 2019 10-Q 2019-08-09
Q1 2019 201M +37.9M +23.3% Mar 1, 2019 10-K 2019-03-15
Q3 2018 182M +19.6M +12.1% Nov 1, 2018 10-Q 2018-11-09
Q2 2018 164M +1.41M +0.87% Aug 1, 2018 10-Q 2018-08-08
Q1 2018 163M +886K +0.55% Mar 1, 2018 10-K 2018-03-15
Q3 2017 162M +6.49M +4.17% Nov 1, 2017 10-Q 2017-11-09
Q2 2017 162M +6.46M +4.15% Aug 1, 2017 10-Q 2017-08-09
Q1 2017 162M +6.33M +4.07% Mar 1, 2017 8-K 2017-12-15
Q3 2016 156M +63.1K +0.04% Nov 1, 2016 10-Q 2016-11-09
Q2 2016 156M +5.05M +3.35% Jul 29, 2016 10-Q 2016-08-11
Q1 2016 156M +5.23M +3.48% Mar 1, 2016 10-K 2016-03-23
Q3 2015 156M +4.96M +3.29% Nov 2, 2015 10-Q 2015-11-09
Q2 2015 151M +63.8K +0.04% Jul 31, 2015 10-Q 2015-08-10
Q1 2015 150M +635K +0.42% Mar 2, 2015 10-K 2015-03-16
Q3 2014 151M +16.4M +12.2% Oct 31, 2014 10-Q 2014-11-10
Q2 2014 151M +29.2M +24% Aug 1, 2014 10-Q 2014-08-11
Q1 2014 150M +32.1M +27.3% Feb 28, 2014 10-K 2014-03-14
Q3 2013 134M +27M +25.1% Nov 5, 2013 10-Q 2013-11-12
Q2 2013 121M +18M +17.4% Aug 2, 2013 10-Q 2013-08-09
Q1 2013 118M +21.1M +21.9% Mar 1, 2013 10-K/A 2013-03-21
Q3 2012 107M +12.3M +12.9% Nov 2, 2012 10-Q 2012-11-13
Q2 2012 103M +8.79M +9.29% Aug 1, 2012 10-Q 2012-08-09
Q1 2012 96.5M May 4, 2012 10-Q 2012-05-10
Q3 2011 95.1M Nov 1, 2011 10-Q 2011-11-09
Q2 2011 94.7M Aug 1, 2011 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.